No Picture
News

Nucleus Biologics Launches Krakatoa® K500: A Pod-Based, On-Demand Media and Buffer Manufacturing System Transforming Scale Bioproduction

SAN DIEGO–(BUSINESS WIRE)– #bioprocess–Nucleus Biologics launched the Krakatoa® K500, a pod-based, on-demand manufacturing system that produces 35–500L of media and buffers at point of use. Click here to view original post Click Here to Publish/Feature […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Iambic Announces Collaboration with Takeda to Advance AI-Driven Design of Small Molecules

SAN DIEGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced a multi-year technology and discovery collaboration agreement with Takeda that […]

News

New Data Presented at AF Symposium Show Atraverse Medical’s HOTWIRE™ System Mitigates Unintended Left Atrial Injury With Reduced RF Delivery

SAN DIEGO, Feb. 9, 2026 /PRNewswire/ — Atraverse Medical today announced the presentation of new clinical and preclinical data at AF Symposium 2026 in Boston, further validating the safety, performance, and workflow advantages of the […]

No Picture
Industry News

Takeda, Iambic Launch Up-to-$1.7B AI Collaboration

Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs starting with two of Takeda’s therapeutic areas through a multi-year tech and discovery collaboration […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Xenotransplantation: Making Silk Purses from Sow Ears

Researchers have made rapid progress in recent years toward understanding the molecular underpinnings of non-human organ rejection, offering hope that organ shortages can be overcome through xenotransplantation. Over 100,000 patients are on organ transplant waiting […]

No Picture
News

Denali Therapeutics Presents Enzyme TransportVehicle™ Progress Across Three Clinical Programs for Treatment of Lysosomal Storage Disorders at 2026 WORLDSymposium™

SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI) today announced data from programs in Hunter syndrome (mucopolysaccharidosis type II, MPS II), Sanfilippo syndrome type A (MPS IIIA) and […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Novel Antibody Technologies Strive for Clinical Impact

Since the landmark 2019 approval of Enhertu, the antibody-drug conjugate (ADC) drug that quickly became a blockbuster breast cancer therapy—with global sales surpassing $1.6 billion in 2022—industry investment in ADC technologies has surged. ADCs marry […]


ADVERTISEMENT — Advertise With Biotech Networks
News

The Power of Story

At the 2026 Indigi-Con Creators Symposium, the Indigenous Futures Institute will bring artists and advocates together to celebrate Indigenous culture, storytelling and creativity, and uplifting Indigenous knowledge through community-based programming for the next generation. Click […]

News

American Specialty Health Introduces Site-Of-Care Program to Help Lower the Cost of Outpatient Physical and Occupational Therapy

AHIP Spotlights Site-of-Care Price Differences as One of Four Reasons Why Prices Continue to Rise Across the Healthcare Industry SAN DIEGO, Feb. 5, 2026 /PRNewswire/ — American Specialty Health (ASH) recently launched a new market-leading […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026

Conference Call Scheduled for Wednesday, February 11 at 4:30 p.m. Eastern Time SAN DIEGO, Feb. 4, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel […]

No Picture
News

Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, after the close of the U.S. financial markets. Acadia’s […]